Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lisa V Hampson

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
Trials|October 26, 2019
Correction to: Choosing the target difference and undertaking and reporting the sample size calculation for a randomised controlled trial - the development of the DELTA2 guidanceWilliam Sones, Steven A Julious, Joanne C Rothwell, et al.
British Journal of Cancer|February 14, 2018
A phase I trial of the γ-secretase inhibitor MK-0752 in combination with gemcitabine in patients with pancreatic ductal adenocarcinomaNatalie Cook, Bristi Basu, Donna-Michelle Smith, et al.
BMC Medicine|March 2, 2018
Adaptive designs in clinical trials: why use them, and how to run and report themPhilip Pallmann, Alun W Bedding, Babak Choodari-Oskooei, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 24, 2021
Mycophenolate Mofetil Versus Cyclophosphamide for Remission Induction in Childhood Polyarteritis Nodosa: An Open-Label, Randomized, Bayesian Noninferiority TrialPaul A Brogan, Barbara Arch, Helen Hickey, et al.
Health Technology Assessment (Winchester, England)|October 30, 2019
Practical help for specifying the target difference in sample size calculations for RCTs: the DELTA<sup>2</sup> five-stage study, including a workshopJonathan A Cook, Steven A Julious, William Sones, et al.
Trials|November 8, 2018
DELTA<sup>2</sup> guidance on choosing the target difference and undertaking and reporting the sample size calculation for a randomised controlled trialJonathan A Cook, Steven A Julious, William Sones, et al.
Plos One|March 31, 2015
Elicitation of expert prior opinion: application to the MYPAN trial in childhood polyarteritis nodosaLisa V Hampson, John Whitehead, Despina Eleftheriou, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Trials|October 26, 2019
Correction to: Choosing the target difference and undertaking and reporting the sample size calculation for a randomised controlled trial - the development of the DELTA2 guidanceWilliam Sones, Steven A Julious, Joanne C Rothwell, et al.
British Journal of Cancer|February 14, 2018
A phase I trial of the γ-secretase inhibitor MK-0752 in combination with gemcitabine in patients with pancreatic ductal adenocarcinomaNatalie Cook, Bristi Basu, Donna-Michelle Smith, et al.
BMC Medicine|March 2, 2018
Adaptive designs in clinical trials: why use them, and how to run and report themPhilip Pallmann, Alun W Bedding, Babak Choodari-Oskooei, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 24, 2021
Mycophenolate Mofetil Versus Cyclophosphamide for Remission Induction in Childhood Polyarteritis Nodosa: An Open-Label, Randomized, Bayesian Noninferiority TrialPaul A Brogan, Barbara Arch, Helen Hickey, et al.
Health Technology Assessment (Winchester, England)|October 30, 2019
Practical help for specifying the target difference in sample size calculations for RCTs: the DELTA<sup>2</sup> five-stage study, including a workshopJonathan A Cook, Steven A Julious, William Sones, et al.
Trials|November 8, 2018
DELTA<sup>2</sup> guidance on choosing the target difference and undertaking and reporting the sample size calculation for a randomised controlled trialJonathan A Cook, Steven A Julious, William Sones, et al.
Plos One|March 31, 2015
Elicitation of expert prior opinion: application to the MYPAN trial in childhood polyarteritis nodosaLisa V Hampson, John Whitehead, Despina Eleftheriou, et al.
Pageof 4